ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,890.10
-0.91%
S&P ASX All Technology
3,489.20
-4.01%
Brent Oil
69.825
1.14%
US Dollar vs AUD
1.59189
-0.05%
Bitcoin
81,656.90
4.06%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. eFFECTOR Therapeutics Inc (CE) (EFTR) Share Price

eFFECTOR Therapeutics Inc (CE)

eFFECTOR Therapeutics Inc (CE) (EFTR)

USOTC
0.0006
0.00
(0.00%)
Closed 11 March 7:00AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.0006
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.17
Market Cap
2.823k
Previous Close
0.0006
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,949
Shares Outstanding
4,704,409
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-7.61
Revenue
-
Net Profit
-35.81M

About eFFECTOR Therapeutics Inc (CE)

Sector
Blank Checks
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
2020
eFFECTOR Therapeutics Inc (CE) is listed in the Blank Checks sector of the OTCMarkets with ticker EFTR. The last closing price for eFFECTOR Therapeutics (CE) was US$0. Over the last year, eFFECTOR Therapeutics (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.17.

eFFECTOR Therapeutics (CE) currently has 4,704,409 shares in issue. The market capitalisation of eFFECTOR Therapeutics (CE) is US$2,822.65 . eFFECTOR Therapeutics (CE) has a price to earnings ratio (PE ratio) of 0.00.

Ask ADVFN Intelligence (AI)

EFTR Latest News

More News

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 August 2024
EFTR (0.00%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 August 2024
EFTR (0.00%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 August 2024
EFTR (0.00%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 August 2024
EFTR (0.00%)

Form 15-12G - Securities registration termination [Section 12(g)]
Edgar (US Regulatory)
31 July 2024
EFTR (0.00%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
31 July 2024
EFTR (0.00%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
31 July 2024
EFTR (0.00%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
31 July 2024
EFTR (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00060.00060.000243540.00053383CS
40.00042000.00020.00060.000216080.00047119CS
120.00042000.00020.00061.0E-679490.00021394CS
26-0.0464-98.72340425530.0470.061.0E-6189730.01753044CS
52-0.0994-99.40.10.171.0E-6489720.05392668CS
156-0.0994-99.40.10.171.0E-6489720.05392668CS
260-0.0994-99.40.10.171.0E-6489720.05392668CS

EFTR - Frequently Asked Questions (FAQ)

What is the current eFFECTOR Therapeutics (CE) share price?
The current share price of eFFECTOR Therapeutics (CE) is US$ 0.0006
How many eFFECTOR Therapeutics (CE) shares are in issue?
eFFECTOR Therapeutics (CE) has 4,704,409 shares in issue
What is the market cap of eFFECTOR Therapeutics (CE)?
The market capitalisation of eFFECTOR Therapeutics (CE) is USD 2.82k
What is the 1 year trading range for eFFECTOR Therapeutics (CE) share price?
eFFECTOR Therapeutics (CE) has traded in the range of US$ 0.000001 to US$ 0.17 during the past year
What is the reporting currency for eFFECTOR Therapeutics (CE)?
eFFECTOR Therapeutics (CE) reports financial results in USD
What is the latest annual profit for eFFECTOR Therapeutics (CE)?
The latest annual profit of eFFECTOR Therapeutics (CE) is USD -35.81M
What is the registered address of eFFECTOR Therapeutics (CE)?
The registered address for eFFECTOR Therapeutics (CE) is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
Which industry sector does eFFECTOR Therapeutics (CE) operate in?
eFFECTOR Therapeutics (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02215
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02215
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02215
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discussion

View Full Feed
rolvram rolvram 5 minutes ago
Trump is buying a Tesla
TSLA
Richard Thomas Richard Thomas 6 minutes ago
Ao, the agm is the 20th.
NB
plugger plugger 8 minutes ago
A verse from Psalm that is deep--deep--deep in my heart, you see while I was in the hospital with my heart valve replacement for days I lay there right on the fence of stepping off into eternity, but up towards the ceiling going around in a circle ( like the ticker on a tv screen) was the Lords pra
ChannelTrader ChannelTrader 9 minutes ago
Yeah, just saw that, wow.
work-n-hard work-n-hard 13 minutes ago
Algo's set to cover? (Borrow Fee 201%)
MLGO
pdicamillo1 pdicamillo1 14 minutes ago
Excellent find on this potential contract opportunity for Lifeloc Technologies. If you haven't done so already, I would like to share this info when I ask the CEO a couple questions. I would like to find out when the annual shareholders meeting is going to be held. I want to make it a point to ma
LCTC
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
FVRR
Fiverr authorizes additional share repurchases of up to $100M
Fiverr International announced that on March 10, its Board of Directors has authorized additional repurchases of up to $100M of ordinary shares under its share repurchase program.
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
SPX, SPY, $ECON
Citi cuts U.S equities with exceptionalism 'at least pausing'
Citi strategists downgraded U.S equities to neutral from
ECON
Rodney5 Rodney5 17 minutes ago
“Imagine that in some private business you own a small share that cost you $1,000. One of your partners, named Mr. Market, is very obliging indeed. Every day he tells you what he thinks your interest is worth and furthermore offers either to buy you out or to sell you an additional interest on that
FNMA
Investor082 Investor082 18 minutes ago
He seems to be a pathological liar, just like LP, LG, and DI.
NWBO
BelgianCook BelgianCook 18 minutes ago
That $100 seems a bit excessive.
I mean, I'd be thrilled. But that is likely not going to happen.
LWLG
KILLAZILLA KILLAZILLA 19 minutes ago
XERI DISCLAIMER:
This is sponsored content, 24/7 MARKET NEWS INC (24/7) has been compensated, or expects to be, to produce and distribute digital content for Xeriant. It should be expressly understood that 24/7 is not operated by a licensed broker, a dealer, or a registered investment adviser
XERI
spartex spartex 20 minutes ago
Got this technical update from ZeroHedge email (marketear) this morning - I'm not a premium member but lets see how this goes........

It is early in the session, but SPX has put in a hammer candle so far. Needless to say, we are at very oversold levels. Note previous hammer/inverted h
SPY
Aquahoya Aquahoya 21 minutes ago
I guess we are close seeing some rando just showed up. Hope you are able to get some cheap shares for the ride. Good luck.
VGTL
Patrick Bateman Patrick Bateman 21 minutes ago
No rush to enter but someone is, and has been, trying to buy. 
CBLO
Investor082 Investor082 21 minutes ago
Understaffed, are you kidding me? The reason why they took over 3 years to submit MAA and double/triple check the application before submitting to the UK was so that they could apply to multiple RAs. They simply lied to investors at that point.

When your existence and ability to turn
NWBO
madras50 madras50 21 minutes ago
Really? $1 or .10?
prototype_101 prototype_101 25 minutes ago
SPORTY said, The smart shorts have already cashed in, the remaining are just avaricious and will begin covering in the next 48 to 72 hours.

Ha!! Too funny!! I will personally GUARANTEE if Shorts try to exit in that timeframe the PPS will hit $100 easy!! There is no way that Shorts wil
LWLG
Rodney5 Rodney5 27 minutes ago
“Far more money has been lost by investors trying to anticipate corrections, than lost in the corrections themselves.” It's impossible to time the market, let alone individual stocks. Peter Lynch
FNMA
StayHumble StayHumble 28 minutes ago
$AMC Silver investments Golden💹ShortFilm Xplosion Coming✅💹

"...............enjoy the Show..........wow...."'
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
AMC
Investor082 Investor082 28 minutes ago
They are likely to get sued in Q4 this year. A few shareholders that care about ROI and opportunity cost are going to come together and expose the lies. Thats all I will say.
NWBO

Your Recent History

USOTC
EFTR
eFFECTOR Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads